Skip to main navigation Skip to search Skip to main content

Pembrolizumab plus azacitidine in patients with chemotherapy refractory metastatic colorectal cancer: a single-arm phase 2 trial and correlative biomarker analysis

  • Chaoyuan Kuang
  • , Yongseok Park
  • , Ryan C. Augustin
  • , Yan Lin
  • , Douglas J. Hartman
  • , Lindsey Seigh
  • , Reetesh K. Pai
  • , Weijing Sun
  • , Nathan Bahary
  • , James Ohr
  • , John C. Rhee
  • , Stanley M. Marks
  • , H. Scott Beasley
  • , Yongli Shuai
  • , James G. Herman
  • , Hassane M. Zarour
  • , Edward Chu
  • , James J. Lee
  • , Anuradha Krishnamurthy

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Pembrolizumab plus azacitidine in patients with chemotherapy refractory metastatic colorectal cancer: a single-arm phase 2 trial and correlative biomarker analysis'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Neuroscience

Biochemistry, Genetics and Molecular Biology